Home/Filings/4/0001209191-23-018479
4//SEC Filing

Reyes Joyce 4

Accession 0001209191-23-018479

CIK 0001383701other

Filed

Mar 13, 8:00 PM ET

Accepted

Mar 14, 4:34 PM ET

Size

13.1 KB

Accession

0001209191-23-018479

Insider Transaction Report

Form 4
Period: 2023-03-10
Reyes Joyce
See Remarks
Transactions
  • Award

    Stock Option (right to buy)

    2023-03-10+16,65916,659 total
    Exercise: $0.95Exp: 2033-03-10Common Stock (16,659 underlying)
  • Award

    Stock Option (right to buy)

    2023-03-10+47,41747,417 total
    Exercise: $0.95Exp: 2033-03-10Common Stock (47,417 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2023-03-101,2000 total
    Exercise: $4.80Exp: 2032-02-17Common Stock (1,200 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2023-03-107,8330 total
    Exercise: $3.20Exp: 2032-06-01Common Stock (7,833 underlying)
Footnotes (5)
  • [F1]1/4 of the shares subject to the option vest one year after the date of grant, on 3/10/2024, and the remaining 1/36 of the shares vest on a monthly basis thereafter.
  • [F2]Effective June 2, 2022, the Issuer effected a 1-for-20 reverse stock split of the Company's issued and outstanding common stock, par value $0.0001 per share.
  • [F3]On March 10, 2023, the Issuer and the Reporting Person agreed to cancel the stock option award.
  • [F4]1/4 of the shares subject to the option vested on 9/15/2022 and the remaining 1/36 of the shares vest on a monthly basis thereafter.
  • [F5]1/4 of the shares subject to the option vested one year after the date of grant, on 6/1/2023, and the remaining 1/36 of the shares vest on a monthly basis thereafter.

Issuer

Histogen Inc.

CIK 0001383701

Entity typeother

Related Parties

1
  • filerCIK 0001929891

Filing Metadata

Form type
4
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 4:34 PM ET
Size
13.1 KB